English Health

Dalmia gets approval from Ministry of AYUSH for manufacturing of ASTHA-15 for the treatment of COVID-19

  • “Astha -15” aids in the speedy recovery of COVID-19 patients
  • Dalmia Research gets AYUSH sanction to market a first-of-its-kind COVID Treatment formulation
  • DCRD developed15 herb Ayurvedic formulation is a global first in COVID treatment, puts India as a leading player in COVID pharmaceutics
  • Dalmia gerts India & Ayurveda on World COVID Map


Noida [India] : In possibly, the proudest reason for India to cheer about during these pandemic times, Dalmia Healthcare Limited very soon will be announcing the launch of the polyherbal combination of 15 herbs called Astha-15 for the treatment of COVID-19 along with standard care approved as per AYUSH/ICMR guidelines. This Ayurvedic (Indian System of Medicine) polyherbal capsule has been developed with the rationale to provide a safe and effective Ayurvedic formulation for the patients suffering from COVID and shown remarkable results.

“This is a proud moment for India, our own indigenous Ayurveda and Dalmia Healthcare Limited –has developed Astha-15 for the effective treatment of respiratory disorders in COVID patients,” says Sanjay Dalmia, Chairman, Dalmia Group of Companies. Dalmia’s research arm Dalmia Centre for Research and Development (DCRD) has developed Astha-15 after extensive research and developed this polyherbal combination.

“We are happy to announce that the outcome of the Clinical Trial showed that Astha-15 has significantly reduced the cough and wheezing, improved the respiratory rate and aid in the speedy recovery of COVID-19 patients with the improvement of quality of life during the treatment cycle,” asserts Dalmia.

Aptly named Astha or faith, Astha-15 brings back the faith of the healthcare fraternity in Ayurveda. The pathbreaking medicine acts as a bronchodilator, decongestant, anti-inflammatory and lung detoxifier. It helps in eliminating the infection and regulating the allergic reactions. This has a specific action on the mucosa of the respiratory tract and the muscular walls of the lungs that act as the airways. It has an anti-inflammatory effect which reduces inflammation and congestion inside the lungs. Its continuous use reduces the damage on the lungs and the muscular walls and brings out a significant reversal in their dysfunction. All these disorders which have been found in COVID19 patients have been confirmed to be treated by Astha-15.

Dalmia Healthcare had earlier sought approval for Astha-15 by conducting a clinical trial to evaluate the efficacy and safety of polyherbal combination for the treatment of COVID-19 along with standard care approved as per AYUSH/ICMR guidelines. After two successful phases, Phase III trial was conducted on 120 subjects at multi-centric sites viz. JNUIMSRC, Jaipur, Govt. Medical College & Govt. General hospital, Srikakulam (Old RIMSGGH) and RGMC & CSMH, Thane by following the regulatory guidelines of AYUSH and the Informed Consent Declaration, Insurance Terms and Hospital Ethics Committee approvals which are registered at DCGI to perform the clinical trial. This phase III clinical trial has been registered on CTRI with reg. no. CTRI/2020/06/025590.

Astha-15 will be made available in the First Phase through prescriptions written for mild and moderate COVID patients undergoing treatment in COVID Hospitals. Dalmia Healthcare would be applying for permission/approval of Astha-15 usage in allopathic hospitals, as per the procedure in each hospital.

Dalmia’s Astha-15 will be the first Ayurvedic drug and an indigenous formulation from India in the global market addressing the respiratory disorders in COVID. Its arrival will bring in immediate faster recovery relief to lakhs of COVID patients.

About Dalmia Health Care:

Dalmia Healthcare Limited (DHL), a Dalmia Group Company, has made foray into the healthcare business in the year 2000 and offers plant-based formulations (Ayurvedic/herbal) prepared through scientific validation followed by clinical trials undertaken by its research centre, Dalmia Centre for Research and Development   (DCRD).

The essence of pre-marketing efforts focuses on clinical trials compared and measured with those for various Allopathic drugs indicated for similar conditions. Extensive toxicological studies are conducted while formulating DHL products in order to ensure that our products are safe and devoid of adverse side-effects. All products of Dalmia Healthcare are manufactured and evaluated in accordance with the standards of modern medical parameters.

English Health

The Future of HealthCare is Telehealth

Prayagraj, Allahabad, Uttar Pradesh [India] : It’s safe to say that healthcare has been radically transformed by technology over the last few decades and one of the most important developments has been that of telehealth – the ability to access top quality healthcare remotely without needing to be in physical proximity of the medical professional giving advice.  The basic idea is that patients are connected directly to doctors via video call from the comfort of their own home – taking advantage of the communication technology that we’ve seen connect the whole world.  Telehealth promises to democratize care by bringing the best of the best into your home no matter where you happen to be in the world.

There are a range of applications where telehealth has been found to be particularly valuable including behavioural health services, chronic disease management and professional consultations – all of which are made much more efficient through remote consultations as opposed to being there in person.  In India, for example, there are hundreds of smaller cities in more remote areas where inhabitants simply don’t have access to certain medical specializations or even to routine medical care – purely because of where they live.  And it’s not unique to India – we hear these stories from all around the world.  Medical care is not readily available, it’s not fully distributed.  This is a problem that telehealth can fix.

We’ve heard plenty of these stories here at Sprint Medical We once received a call from a father living in Bhadoi, a small town with limited access to medical care, and he told us about his daughter who had been suffering from chronic kidney disease for 8 years by then.  He was desperate to find a good doctor but after having exhausted all his options in their hometown, he was a bit despondent because it seemed that the care he was looking for just didn’t exist where he was.  Using our telehealth platform, we were able to connect him with a top nephrologist in Canada by the name of Dr Shobhana who was able to provide world-class care at a very reasonable rate  from halfway across the world.  This changed everything for the patient as, all of a sudden, they realised that the medical care they so desperately sought was just a phone call away.  Their location didn’t matter.This is the power of this technology.  It levels the playing field and brings cutting-edge medical care to anyone, anywhere in the world – so that you don’t have to suffer just because of where you happen to be located.

Beyond location, telehealth also tends to lower the cost of medical care because doctors don’t have to cover all the overheads associated with running a physical practice.  The service is stripped down to only what really matters and those cost savings are passed on to the patients who so desperately need it.  Previously, it would have been unheard to suggest that a patient in a Tier 3 city in India could afford medical advice from a leading doctor in North America, but the innovation in telehealth makes that possible.  By removing all the costs in the middle of the process and simply connecting the doctor to the patient directly – the costs become much more reasonable.  It really does promise to open up this industry in a way like we’ve never seen before.There is also great feedback from our Doctors Doctorsas it empowers them to do what they all want to do – help people – without all the distractions that a physical office brings with it.

Another unexpected benefit of telehealth has been what it’s doing to reduce the stigma around medical care.  For certain conditions, there is an element of shame and embarrassment with going into a public medical centre to seek care – that sometimes gets in the way of doing what’s needed to help the associated condition.  Telehealth provides a private opportunity for individuals to seek care without signalling to anyone else that they’re doing so.  Doctors have remarked on how much more honest and vulnerable patients are during these digital consultations because they don’t have the social pressure or expectations of people around them.  This more authentic experience between doctor and patient is a wonderful thing and means that patients are getting the care they need earlier and more effectively than everbefore.

All of these benefits point to why there is so much excitement for this field around the world.  Telehealth is breaking down barriers to receiving care and creating a more convenient, efficient and cost-effective experience for everyone involved.  Regulators are beginning to get their heads around this new form of medical assistance and as they acknowledge the potential, this industry continues to flourish.  It’s fundamentally changing the way we think about medical care and here at Sprint Medical, we couldn’t be more excited and Proudabout it.